tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CLRB Stock Latest News

Cellectar Biosciences announces supply agreement with Ionetix
The FlyCellectar Biosciences announces supply agreement with Ionetix
9d ago
CLRB
Cellectar Biosciences Reports Q3 2025 Financial Progress
PremiumCompany Announcements
Cellectar Biosciences Reports Q3 2025 Financial Progress
1M ago
CLRB
Cellectar Biosciences: Positive Outlook Amidst Challenges
PremiumCompany Announcements
Cellectar Biosciences: Positive Outlook Amidst Challenges
1M ago
CLRB
Cellectar Biosciences reports Q3 EPS ($1.41), consensus ($2.53)
PremiumThe Fly
Cellectar Biosciences reports Q3 EPS ($1.41), consensus ($2.53)
1M ago
CLRB
Cellectar Biosciences Inc (CLRB) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Cellectar Biosciences Inc (CLRB) Q3 Earnings Cheat Sheet
2M ago
CLRB
Cellectar Biosciences receives RPDD from U.S. FDA for iopofosine I 131
PremiumThe FlyCellectar Biosciences receives RPDD from U.S. FDA for iopofosine I 131
2M ago
CLRB
Cellectar Biosciences files to sell 2.1M shares of common stock for holders
Premium
The Fly
Cellectar Biosciences files to sell 2.1M shares of common stock for holders
2M ago
CLRB
Cellectar Biosciences presents posters at AACR on CLR 121225, CLR 225
Premium
The Fly
Cellectar Biosciences presents posters at AACR on CLR 121225, CLR 225
2M ago
CLRB
Cellectar Biosciences Raises $5.8M Through Warrant Exercise
PremiumCompany Announcements
Cellectar Biosciences Raises $5.8M Through Warrant Exercise
3M ago
8K
CLRB
Cellectar Biosciences enters agreements to raise $5.8M
PremiumThe Fly
Cellectar Biosciences enters agreements to raise $5.8M
3M ago
CLRB
EMA news ‘a substantial positive catalyst’ for Cellectar, says Oppenheimer
PremiumThe Fly
EMA news ‘a substantial positive catalyst’ for Cellectar, says Oppenheimer
3M ago
CLRB
Cellectar Biosciences Receives EMA Advice on Drug Filing
PremiumCompany Announcements
Cellectar Biosciences Receives EMA Advice on Drug Filing
3M ago
8K
CLRB
Cellectar says EMA confirms eligibility to file for CMA for iopofosine I 131
PremiumThe FlyCellectar says EMA confirms eligibility to file for CMA for iopofosine I 131
3M ago
CLRB
Cellectar Biosciences says Iopofosine I 131 well tolerated in case studies
Premium
The Fly
Cellectar Biosciences says Iopofosine I 131 well tolerated in case studies
3M ago
CLRB
Cellectar, Evestia entered into agreement for Phase 1b study of CLR 125
Premium
The Fly
Cellectar, Evestia entered into agreement for Phase 1b study of CLR 125
3M ago
CLRB
Cellectar Biosciences, ITM enter supply agreement for GMP-grade Ac-225
PremiumThe Fly
Cellectar Biosciences, ITM enter supply agreement for GMP-grade Ac-225
3M ago
CLRB
Cellectar to attend at Oppenheimer Targeted Radiopharmaceuticals summit
PremiumThe Fly
Cellectar to attend at Oppenheimer Targeted Radiopharmaceuticals summit
4M ago
CLRB
Cellectar Biosciences Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Cellectar Biosciences Earnings Call: Progress Amid Challenges
4M ago
CLRB
Cellectar Biosciences Reports Q2 2025 Financial Results
PremiumCompany Announcements
Cellectar Biosciences Reports Q2 2025 Financial Results
4M ago
CLRB
Cellectar Biosciences target adjusted to $18 from $3 at Roth Capital
PremiumThe FlyCellectar Biosciences target adjusted to $18 from $3 at Roth Capital
4M ago
CLRB
Cellectar Biosciences reports Q2 EPS ($3.39), consensus ($3.70)
Premium
The Fly
Cellectar Biosciences reports Q2 EPS ($3.39), consensus ($3.70)
4M ago
CLRB
CLRB Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CLRB Upcoming Earnings Report: What to Expect?
4M ago
CLRB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >